Form 8-K - Current report:
SEC Accession No. 0001193125-23-138950
Filing Date
2023-05-09
Accepted
2023-05-09 08:15:01
Documents
13
Period of Report
2023-05-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d421269d8k.htm   iXBRL 8-K 31503
2 EX-99.1 d421269dex991.htm EX-99.1 9818
  Complete submission text file 0001193125-23-138950.txt   177344

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vigl-20230508.xsd EX-101.SCH 2858
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vigl-20230508_lab.xml EX-101.LAB 19499
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vigl-20230508_pre.xml EX-101.PRE 12161
7 EXTRACTED XBRL INSTANCE DOCUMENT d421269d8k_htm.xml XML 3604
Mailing Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472
Business Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472 857-254-4445
Vigil Neuroscience, Inc. (Filer) CIK: 0001827087 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41200 | Film No.: 23900089
SIC: 2836 Biological Products, (No Diagnostic Substances)